» Articles » PMID: 35402848

Small Nucleolar RNA is Potential As a Novel Player in Leukemogenesis and Clinical Application

Overview
Journal Blood Sci
Date 2022 Apr 11
PMID 35402848
Authors
Affiliations
Soon will be listed here.
Abstract

Lack of clarity of the mechanisms that underlie leukemogenesis obstructs the diagnosis, prognosis, and treatment of leukemia. Research has found that small nuclear RNA (snoRNA) plays an essential role in leukemia. These small non-coding RNAs are involved in ribosome biogenesis, including the 2'-O-methylation and pseudouridylation of precursor ribosomal RNA (pre-rRNA), and pre-rRNA splicing. Recently, many snoRNAs were found to be orphans that have no predictable RNA modification targets, but these RNAs have always been found to be located in different subcellular organelles, and they play diverse roles. Using high-throughput technology, snoRNA expression profiles have been revealed in leukemia, and some of the deregulated snoRNAs may regulate the cell cycle, differentiation, proliferation, and apoptosis in leukemic cells and confer drug resistance during leukemia treatment. In this review, we discuss the expression profiles and functions of snoRNAs, particularly orphan snoRNAs, in leukemia. It is possible that the dysregulated snoRNAs are promising diagnosis and prognosis markers for leukemia, which may serve as potential therapeutic targets in leukemia treatment.

Citing Articles

Small nucleolar RNAs: the hidden precursors of cancer ribosomes.

Faucher-Giguere L, de Preval B, Rivera A, Scott M, Elela S Philos Trans R Soc Lond B Biol Sci. 2025; 380(1921):20230376.

PMID: 40045787 PMC: 11883439. DOI: 10.1098/rstb.2023.0376.


SnoRNAs: The promising targets for anti-tumor therapy.

Hu X, Cui W, Liu M, Zhang F, Zhao Y, Zhang M J Pharm Anal. 2024; 14(11):101064.

PMID: 39634568 PMC: 11613181. DOI: 10.1016/j.jpha.2024.101064.


Transgenerational Transmission of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Effects in Human Granulosa Cells: The Role of MicroRNAs.

Gaspari L, Haouzi D, Gennetier A, Granes G, Soler A, Sultan C Int J Mol Sci. 2024; 25(2).

PMID: 38256218 PMC: 10816780. DOI: 10.3390/ijms25021144.


A contemporary review of snoRNAs in cardiovascular health: RNA modification and beyond.

Jagielski N, Rai A, Rajan K, Mangal V, Garikipati V Mol Ther Nucleic Acids. 2024; 35(1):102087.

PMID: 38178918 PMC: 10765057. DOI: 10.1016/j.omtn.2023.102087.


The snoRNA-like lncRNA LNC-SNO49AB drives leukemia by activating the RNA-editing enzyme ADAR1.

Huang W, Sun Y, Pan Q, Fang K, Chen X, Zeng Z Cell Discov. 2022; 8(1):117.

PMID: 36316318 PMC: 9622897. DOI: 10.1038/s41421-022-00460-9.


References
1.
Wang W, Chen T, Zeng Z, Pan Q, Huang W, Han C . The lncRNA LAMP5-AS1 drives leukemia cell stemness by directly modulating DOT1L methyltransferase activity in MLL leukemia. J Hematol Oncol. 2020; 13(1):78. PMC: 7302350. DOI: 10.1186/s13045-020-00909-y. View

2.
Kasakovski D, Xu L, Li Y . T cell senescence and CAR-T cell exhaustion in hematological malignancies. J Hematol Oncol. 2018; 11(1):91. PMC: 6032767. DOI: 10.1186/s13045-018-0629-x. View

3.
Pelletier J, Thomas G, Volarevic S . Ribosome biogenesis in cancer: new players and therapeutic avenues. Nat Rev Cancer. 2017; 18(1):51-63. DOI: 10.1038/nrc.2017.104. View

4.
Croce C, Calin G . miRNAs, cancer, and stem cell division. Cell. 2005; 122(1):6-7. DOI: 10.1016/j.cell.2005.06.036. View

5.
Darzacq X, Jady B, Verheggen C, Kiss A, Bertrand E, Kiss T . Cajal body-specific small nuclear RNAs: a novel class of 2'-O-methylation and pseudouridylation guide RNAs. EMBO J. 2002; 21(11):2746-56. PMC: 126017. DOI: 10.1093/emboj/21.11.2746. View